Bayer Diagnostics Offers Most Comprehensive Automated Hepatitis (A,B,C) Panel in the US
Bayer HealthCare Diagnostics Division, have received approval from the FDA for its automated HBsAg (hepatitis B surface antigen) and HBsAg Confirmatory assays. The fully automated tests, which are used to aid in the diagnosis and confirmation of acute or chronic hepatitis B infections, are available on the ADVIA Centaur® Immunoassay System.
With this approval, Bayer Diagnostics offers the industrys only complete, FDA-approved automated panel for acute hepatitis testing including assays for HBsAg, HCV1, Anti-HBc IgM and Anti-HAV IgM. In addition to the panel for acute hepatitis, Bayer Diagnostics offers assays for HBsAg Confirmatory, anti-HBs, anti-HBc Total and anti-HAV Total. This brings to eight the total number of hepatitis assays available on the ADVIA Centaurthe most comprehensive, automated hepatitis (A, B and C) testing portfolio available in the United States.
The ADVIA Centaur HBsAg Assay is an in vitro diagnostic immunoassay for the qualitative detection of hepatitis B surface antigen (HBsAg) in human serum and plasma using the ADVIA Centaur system. The ADVIA Centaur HBsAg Confirmatory Assay is an in vitro diagnostic immunoassay for the qualitative confirmation of the presence of hepatitis B surface antigen (HBsAg) in human serum and plasma using the ADVIA Centaur system.
The addition of these assays to the platform allows laboratorians to enhance their level of automation and optimize their efficiency in performing these assays with such features as a fully-automated smart algorithm that identifies samples which require repeat or confirmatory tests. The HBsAg assay also provides a "hot zone" feature that determines, based on the value of the sample results, whether the specimen requires any follow-up tests, effectively reducing the number of tests to be conducted and saving valuable time and labor resources for the lab.
Source: Bayer Diagnostics Corporation View latest company information
Posted: June 27, 2005
[will open your email client]